vs
康美（CNMD）与迈心诺（MASI）财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是迈心诺的1.0倍（$373.2M vs $371.5M）。康美同比增速更快（7.9% vs -26.4%）。迈心诺自由现金流更多（$50.9M vs $41.2M）。过去两年康美的营收复合增速更高（9.3% vs -17.7%）
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
迈心诺（Masimo Corporation）是总部位于美国加利福尼亚州尔湾的健康科技及消费电子企业，核心产品包括面向医院及家用场景的患者监护设备、无创传感器及配套软件平台，同时也布局了消费级音频和可穿戴设备赛道。
CNMD vs MASI — 直观对比
营收规模更大
CNMD
是对方的1.0倍
$371.5M
营收增速更快
CNMD
高出34.3%
-26.4%
自由现金流更多
MASI
多$9.7M
$41.2M
两年增速更快
CNMD
近两年复合增速
-17.7%
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $373.2M | $371.5M |
| 净利润 | — | $-100.4M |
| 毛利率 | 58.5% | 62.1% |
| 营业利润率 | 9.8% | 22.5% |
| 净利率 | — | -27.0% |
| 营收同比 | 7.9% | -26.4% |
| 净利润同比 | — | -1124.5% |
| 每股收益（稀释后） | $0.54 | $-1.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNMDMASI
| Q4 25 | $373.2M | — | ||
| Q3 25 | $337.9M | $371.5M | ||
| Q2 25 | $342.3M | $370.9M | ||
| Q1 25 | $321.3M | $372.0M | ||
| Q4 24 | $345.9M | $600.7M | ||
| Q3 24 | $316.7M | $504.6M | ||
| Q2 24 | $332.1M | $496.3M | ||
| Q1 24 | $312.3M | $492.8M |
净利润CNMDMASI
| Q4 25 | — | — | ||
| Q3 25 | $2.9M | $-100.4M | ||
| Q2 25 | $21.4M | $51.3M | ||
| Q1 25 | $6.0M | $-170.7M | ||
| Q4 24 | — | $-349.6M | ||
| Q3 24 | $49.0M | $9.8M | ||
| Q2 24 | $30.0M | $16.0M | ||
| Q1 24 | $19.7M | $18.9M |
毛利率CNMDMASI
| Q4 25 | 58.5% | — | ||
| Q3 25 | 49.2% | 62.1% | ||
| Q2 25 | 55.0% | 62.9% | ||
| Q1 25 | 55.3% | 62.9% | ||
| Q4 24 | 57.3% | 40.7% | ||
| Q3 24 | 56.5% | 52.2% | ||
| Q2 24 | 55.3% | 51.3% | ||
| Q1 24 | 55.1% | 49.0% |
营业利润率CNMDMASI
| Q4 25 | 9.8% | — | ||
| Q3 25 | 3.5% | 22.5% | ||
| Q2 25 | 11.1% | 17.4% | ||
| Q1 25 | 5.0% | 21.0% | ||
| Q4 24 | 15.2% | -59.8% | ||
| Q3 24 | 20.7% | 6.0% | ||
| Q2 24 | 14.2% | 5.7% | ||
| Q1 24 | 11.2% | 6.9% |
净利率CNMDMASI
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | -27.0% | ||
| Q2 25 | 6.3% | 13.8% | ||
| Q1 25 | 1.9% | -45.9% | ||
| Q4 24 | — | -58.2% | ||
| Q3 24 | 15.5% | 1.9% | ||
| Q2 24 | 9.0% | 3.2% | ||
| Q1 24 | 6.3% | 3.8% |
每股收益（稀释后）CNMDMASI
| Q4 25 | $0.54 | — | ||
| Q3 25 | $0.09 | $-1.84 | ||
| Q2 25 | $0.69 | $0.94 | ||
| Q1 25 | $0.19 | $-3.12 | ||
| Q4 24 | $1.09 | $-6.54 | ||
| Q3 24 | $1.57 | $0.18 | ||
| Q2 24 | $0.96 | $0.29 | ||
| Q1 24 | $0.63 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $312.3M |
| 总债务越低越好 | $834.2M | $559.1M |
| 股东权益账面价值 | $1.0B | $810.0M |
| 总资产 | $2.3B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.81× | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资CNMDMASI
| Q4 25 | — | — | ||
| Q3 25 | — | $312.3M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $130.8M | ||
| Q4 24 | — | $177.6M | ||
| Q3 24 | — | $158.5M | ||
| Q2 24 | — | $129.6M | ||
| Q1 24 | — | $157.6M |
总债务CNMDMASI
| Q4 25 | $834.2M | — | ||
| Q3 25 | $853.0M | $559.1M | ||
| Q2 25 | $881.1M | $613.7M | ||
| Q1 25 | $891.4M | $651.0M | ||
| Q4 24 | $905.1M | $765.2M | ||
| Q3 24 | $940.1M | $772.6M | ||
| Q2 24 | $965.2M | $781.6M | ||
| Q1 24 | $990.1M | $876.0M |
股东权益CNMDMASI
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.0B | $810.0M | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $977.6M | $946.4M | ||
| Q4 24 | $962.7M | $1.1B | ||
| Q3 24 | $932.9M | $1.5B | ||
| Q2 24 | $881.8M | $1.4B | ||
| Q1 24 | $854.7M | $1.4B |
总资产CNMDMASI
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $1.8B | ||
| Q2 25 | $2.3B | $2.4B | ||
| Q1 25 | $2.3B | $2.3B | ||
| Q4 24 | $2.3B | $2.6B | ||
| Q3 24 | $2.3B | $3.1B | ||
| Q2 24 | $2.3B | $2.9B | ||
| Q1 24 | $2.3B | $3.0B |
负债/权益比CNMDMASI
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | 0.69× | ||
| Q2 25 | 0.88× | 0.59× | ||
| Q1 25 | 0.91× | 0.69× | ||
| Q4 24 | 0.94× | 0.73× | ||
| Q3 24 | 1.01× | 0.53× | ||
| Q2 24 | 1.09× | 0.57× | ||
| Q1 24 | 1.16× | 0.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.3M | $56.8M |
| 自由现金流经营现金流 - 资本支出 | $41.2M | $50.9M |
| 自由现金流率自由现金流/营收 | 11.0% | 13.7% |
| 资本支出强度资本支出/营收 | 1.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $150.9M | $191.0M |
8季度趋势，按日历期对齐
经营现金流CNMDMASI
| Q4 25 | $46.3M | — | ||
| Q3 25 | $53.7M | $56.8M | ||
| Q2 25 | $29.1M | $69.4M | ||
| Q1 25 | $41.5M | $31.1M | ||
| Q4 24 | $43.3M | $50.5M | ||
| Q3 24 | $51.2M | $25.6M | ||
| Q2 24 | $43.3M | $74.5M | ||
| Q1 24 | $29.1M | $45.8M |
自由现金流CNMDMASI
| Q4 25 | $41.2M | — | ||
| Q3 25 | $48.5M | $50.9M | ||
| Q2 25 | $23.4M | $65.6M | ||
| Q1 25 | $37.8M | $28.5M | ||
| Q4 24 | $39.3M | $46.0M | ||
| Q3 24 | $47.8M | $16.9M | ||
| Q2 24 | $39.7M | $66.9M | ||
| Q1 24 | $27.1M | $37.6M |
自由现金流率CNMDMASI
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.4% | 13.7% | ||
| Q2 25 | 6.8% | 17.7% | ||
| Q1 25 | 11.8% | 7.7% | ||
| Q4 24 | 11.4% | 7.7% | ||
| Q3 24 | 15.1% | 3.3% | ||
| Q2 24 | 12.0% | 13.5% | ||
| Q1 24 | 8.7% | 7.6% |
资本支出强度CNMDMASI
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.5% | 1.6% | ||
| Q2 25 | 1.7% | 1.0% | ||
| Q1 25 | 1.2% | 0.7% | ||
| Q4 24 | 1.2% | 0.7% | ||
| Q3 24 | 1.1% | 1.7% | ||
| Q2 24 | 1.1% | 1.5% | ||
| Q1 24 | 0.7% | 1.7% |
现金转化率CNMDMASI
| Q4 25 | — | — | ||
| Q3 25 | 18.78× | — | ||
| Q2 25 | 1.36× | 1.35× | ||
| Q1 25 | 6.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.05× | 2.61× | ||
| Q2 24 | 1.44× | 4.66× | ||
| Q1 24 | 1.48× | 2.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
MASI
暂无分部数据
